James Healy, Director at Karuna Therapeutics, Inc. (KRTX), bought 156,250 shares at $96.00 ($15.0M) on 2019-11-25, disclosed to the SEC on 2019-11-25.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| RAPP | BUY | 2024-06-10 | $9.5M | — | Filing → |
| AVBP | BUY | 2024-01-31 | $8.0M | — | Filing → |
| NTRA | SELL | 2023-12-22 | $37.8M | — | Filing → |